Information Holdings acquires CDC Solutions.Information Holdings Inc. (IHI IHI Institute for Healthcare Improvement (Boston, MA, USA) IHI Ishikawajima-Harima Heavy Industries (Japan, ship building, aerospace & others) IHI Institute of History IHI I'd Hit It ; Stamford, CT) has acquired CDC See Control Data, century date change and Back Orifice. CDC - Control Data Corporation Solutions (Conshohoken, PA/Chippenham, UK), a provider of regulatory publishing solutions for the life sciences industry, from venture capital firms Name Location Founding date Managing Partners/Directors Specialty Capital managed 5AM Ventures Menlo Park, CA; Waltham, MA 2002 John Diekman, PhD (managing partner), Scott Rocklage, PhD (managing partner), Andrew Schwab (managing partner) life sciences $200M [1] 3i plc. (London/Menlo Park, CA), Quester Capital Management (London) and NIF NIF See: Note issuance facility Ventures (Palo Alto, CA/Tokyo). CDC was purchased through IHI's Liquent subsidiary for approximately $19.1 million in cash, with a potential additional consideration of between 54-14 million depending on future operating results. IHI was represented by The van Tulleken Co. (New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of ). Established in 1994, CDC provides software and related services that are designed to facilitate the preparation and submission of regulatory filings in the life sciences industry. Its products are used by pharmaceutical, biotechnology and medical device companies to create new drug applications, reports, proposals and technical documentation. IHI said it expects CDC to generate revenues of $12-13 million for the year ending Dec. 31, 2003. IHI president/ceo Mason Slaine said that IHI "now has the most complete suite of offerings related to new drug applications (NDAs) of any company in the world. IHI's presence will now be global with Liquent's historic strength in North America, CDC's strong presence in the UK and Asia and (IHI's) IDRAC's presence and strength in central Europe." |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion